NCT00000280

Brief Summary

The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Sep 1994

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 1994

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 1999

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 1999

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 20, 1999

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 21, 1999

Completed
Last Updated

April 25, 2017

Status Verified

December 1, 2002

Enrollment Period

4.9 years

First QC Date

September 20, 1999

Last Update Submit

April 21, 2017

Conditions

Cocaine-Related Disorders

Keywords

cocaine

Outcome Measures

Primary Outcomes (1)

  • Cocaine effects

Interventions

NimodipineDRUG

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Please contact site for information.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

VA Connecticut Healthcare System

New Haven, Connecticut, 06519, United States

Location

MeSH Terms

Conditions

Cocaine-Related Disorders

Interventions

Nimodipine

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

DihydropyridinesPyridinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsNicotinic Acids

Study Officials

  • Thomas R Kosten, M.D.

    VA Connecticut Healthcare System

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Purpose
TREATMENT
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 1999

First Posted

September 21, 1999

Study Start

September 1, 1994

Primary Completion

August 1, 1999

Study Completion

August 1, 1999

Last Updated

April 25, 2017

Record last verified: 2002-12

Locations

US(1)